NASDAQ:INMD InMode (INMD) Stock Price, News & Analysis $14.10 +0.20 (+1.44%) Closing price 05/18/2026 04:00 PM EasternExtended Trading$13.99 -0.11 (-0.81%) As of 07:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About InMode Stock (NASDAQ:INMD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get InMode alerts:Sign Up Key Stats Today's Range$13.92▼$14.1550-Day Range$12.76▼$14.6552-Week Range$12.72▼$16.74Volume967,515 shsAverage Volume768,588 shsMarket Capitalization$893.36 millionP/E Ratio10.37Dividend YieldN/APrice Target$16.00Consensus RatingHold Company Overview InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures. InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime. The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America. In addition to product deployment, InMode provides training, clinical support and marketing services to practitioners to facilitate the adoption of its platforms. Founded in the late 2000s, InMode completed its initial public offering in 2019. Managed by an experienced leadership team with backgrounds in medical device development, its ongoing research and development efforts focus on expanding its aesthetic treatment portfolio and exploring new clinical applications of its energy-based platforms.AI Generated. May Contain Errors. Read More InMode Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks36th Percentile Overall ScoreINMD MarketRank™: InMode scored higher than 36% of companies evaluated by MarketBeat, and ranked 728th out of 859 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingHold Consensus RatingInMode has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 6 hold ratings, and 1 sell rating.Upside PotentialInMode has a consensus price target of $16.00, representing about 13.5% upside from its current price of $14.10.Amount of Analyst CoverageInMode has only been the subject of 2 research reports in the past 90 days.Read more about InMode's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of InMode is 10.37, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.48.Price to Earnings Ratio vs. SectorThe P/E ratio of InMode is 10.37, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 20.63.Price to Book Value per Share RatioInMode has a P/B Ratio of 1.31. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about InMode's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.60% of the float of InMode has been sold short.Short Interest Ratio / Days to CoverInMode has a short interest ratio ("days to cover") of 6.11.Change versus previous monthShort interest in InMode has recently increased by 1.69%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInMode does not currently pay a dividend.Dividend GrowthInMode does not have a long track record of dividend growth. News and Social Media3.1 / 5News SentimentN/A News SentimentInMode has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for InMode this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for INMD on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows2 people have added InMode to their MarketBeat watchlist in the last 30 days. Company Ownership1.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, InMode insiders have not sold or bought any company stock.Percentage Held by Insiders6.92% of the stock of InMode is held by insiders.Percentage Held by Institutions68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about InMode's insider trading history. Receive INMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INMD Stock News HeadlinesInMode to Present at Upcoming Investor Conferences and EventsMay 13, 2026 | prnewswire.comInmode Earnings Call: Growth Intact, Margins Under StrainMay 10, 2026 | theglobeandmail.comBefore you buy SpaceX shares, consider this alternative approachSpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.May 19 at 1:00 AM | Weiss Ratings (Ad)Haleon (NYSE:HLN) vs. InMode (NASDAQ:INMD) Head-To-Head ReviewMay 10, 2026 | americanbankingnews.comAnalysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and InMode (INMD)May 8, 2026 | theglobeandmail.comInMode Ltd. (NASDAQ:INMD) Given Consensus Rating of "Hold" by BrokeragesMay 8, 2026 | americanbankingnews.comInMode (INMD) Q1 2026 Earnings Call TranscriptMay 7, 2026 | finance.yahoo.comInMode Ltd. (INMD) Q1 2026 Earnings Call TranscriptMay 6, 2026 | seekingalpha.comSee More Headlines INMD Stock Analysis - Frequently Asked Questions How have INMD shares performed this year? InMode's stock was trading at $14.69 on January 1st, 2026. Since then, INMD shares have decreased by 4.0% and is now trading at $14.10. How were InMode's earnings last quarter? InMode Ltd. (NASDAQ:INMD) released its quarterly earnings data on Wednesday, May, 6th. The healthcare company reported $0.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.30 by $0.05. The business's revenue for the quarter was up 5.3% on a year-over-year basis. Read the conference call transcript. When did InMode's stock split? Shares of InMode split on the morning of Thursday, September 30th 2021.The 2-1 split was announced on Friday, September 17th 2021. The newly issued shares were issued to shareholders after the closing bell on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. Does InMode have any subsidiaries? InMode subsidiaries include Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd.. When did InMode IPO? InMode (INMD) raised $75 million in an initial public offering on Thursday, August 8th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Barclays, UBS Investment Bank and Canaccord Genuity acted as the underwriters for the IPO and Baird was co-manager. Who are InMode's major shareholders? InMode's top institutional shareholders include Renaissance Technologies LLC (4.08%), Steel Partners Holdings L.P. (2.83%), Systematic Financial Management LP (1.82%) and Janus Henderson Group PLC (1.47%). How do I buy shares of InMode? Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InMode own? Based on aggregate information from My MarketBeat watchlists, some other companies that InMode investors own include Symbotic (SYM), JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Voya Infrastructure, Industrials and Materials Fund (IDE), Voyager Therapeutics (VYGR), Humana (HUM), American Water Works (AWK) and Waste Connections (WCN). Company Calendar Last Earnings5/06/2026Today5/19/2026Jefferies Global Healthcare Conference 20266/03/2026Next Earnings (Estimated)7/23/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (51m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 INMD's financial health is in the Red zone, according to TradeSmith. INMD has been in this zone for over 51 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:INMD CIK1742692 Webwww.inmodemd.com Phone972-4909-7470FaxN/AEmployees480Year Founded2008Price Target and Rating Average Price Target for InMode$16.00 High Price Target$19.00 Low Price Target$14.00 Potential Upside/Downside+13.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage8 Analysts Profitability EPS (Trailing Twelve Months)$1.36 Trailing P/E Ratio10.37 Forward P/E RatioN/A P/E GrowthN/ANet Income$93.83 million Net Margins23.27% Pretax Margin27.28% Return on Equity13.47% Return on Assets11.95% Debt Debt-to-Equity RatioN/A Current Ratio8.80 Quick Ratio7.88 Sales & Book Value Annual Sales$374.64 million Price / Sales2.38 Cash Flow$1.51 per share Price / Cash Flow9.32 Book Value$10.78 per share Price / Book1.31Miscellaneous Outstanding Shares63,359,000Free Float58,975,000Market Cap$893.36 million OptionableOptionable Beta1.97 Social Links 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:INMD) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredThe Iran War Just Broke the Gold MarketThe Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged...Behind the Markets | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredIs the SpaceX IPO “Rigged?”The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
